KELSEY FORTIER: Open Payments
NPI 1003355249 · AUSTELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$307 in 15 payments from 8 companies in 2025. Trend: 2023 $107 · 2024 $216 · 2025 $307
Food & beverage: $307
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $89 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| Abbott Laboratories | 2 | $42 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Dexcom, Inc. | 1 | $24 |
| Biogen, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: REXULTI, MOUNJARO, FREESTYLE LIBRE 3, JARDIANCE, INSPIRE, Dexcom G6 Transmitter, LEQEMBI, UBRELVY.
Industry payments across GA — which companies pay providers there.
